Industry Research Reports
Global Circulating Tumor Cells Market Research Report 2025
Industry: Medical Care
Published Date: 2025-08-05
Pages: 93 Pages
Report ld: 3472058
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Circulating Tumor Cells Market Size(US$)
CAGR 2025-2031
20.4%
Market Size,2031
USD 8,259
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,711 million
Market Forecast in 2031(Value)
US$ 8,259 million
CAGR
20.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Circulating Tumor Cells was valued at US$ 2291 million in the year 2024 and is projected to reach a revised size of US$ 8259 million by 2031, growing at a CAGR of 20.4% during the forecast period.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
The circulating tumor cells (CTC) market is gaining significant traction due to its critical role in cancer detection, prognosis, and treatment monitoring. CTCs are cancer cells that have shed from the primary tumor into the bloodstream, offering a minimally invasive method for liquid biopsy. This technology is becoming increasingly important as it enables early detection, real-time disease monitoring, and personalized therapy selection without the need for invasive tissue biopsies. Key drivers include rising cancer incidence globally, advancements in microfluidics and next-generation sequencing, and growing demand for precision medicine solutions.
The market is witnessing innovations in CTC detection and isolation technologies, such as immunomagnetic separation, microfluidic devices, and PCR-based methods, which enhance accuracy and sensitivity. Pharmaceutical and diagnostic companies are heavily investing in research collaborations and clinical trials to integrate CTC analysis into cancer care protocols. Moreover, the integration of artificial intelligence and bioinformatics for interpreting complex CTC data is creating new opportunities for diagnostic and therapeutic advancements. As healthcare systems prioritize early cancer diagnosis and personalized treatment approaches, the adoption of CTC-based diagnostics is expected to grow significantly across clinical and research applications.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells.
The Circulating Tumor Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Menarini-Silicon Biosystems
- Qiagen (Adnagen)
- Advanced Cell Diagnostics
- ApoCell
- Epic Sciences
- Greiner Bio-one GmbH
- Cynvenio
- SurExamBio-Tech
- Fluxion Biosciences
- Ikonisys
- Hangzhou Watson Biotech
- Biocept
- CytoTrack
- Guangzhou Wondfo Biotech
- Celsee
- Clearbridge Biomedics
- ANGLE plc
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CTC Enrichment
- CTC Detection
- CTC Analysis
Segment by Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Lung Cancer
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells Growth Trends by Region
2.2.1 Global Circulating Tumor Cells Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells Market Dynamics
2.3.1 Circulating Tumor Cells Industry Trends
2.3.2 Circulating Tumor Cells Market Drivers
2.3.3 Circulating Tumor Cells Market Challenges
2.3.4 Circulating Tumor Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells Players by Revenue
3.1.1 Global Top Circulating Tumor Cells Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2020-2025)
3.2 Global Top Circulating Tumor Cells Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells Revenue
3.4 Global Circulating Tumor Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells, Product and Application
3.7 Global Key Players of Circulating Tumor Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells Market Size (2020-2031)
6.2 North America Circulating Tumor Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Circulating Tumor Cells Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Details
11.1.2 Menarini-Silicon Biosystems Business Overview
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction
11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2020-2025)
11.1.5 Menarini-Silicon Biosystems Recent Development
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Details
11.2.2 Qiagen (Adnagen) Business Overview
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction
11.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2020-2025)
11.2.5 Qiagen (Adnagen) Recent Development
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Details
11.3.2 Advanced Cell Diagnostics Business Overview
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction
11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2020-2025)
11.3.5 Advanced Cell Diagnostics Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2020-2025)
11.4.5 ApoCell Recent Development
11.5 Epic Sciences
11.5.1 Epic Sciences Company Details
11.5.2 Epic Sciences Business Overview
11.5.3 Epic Sciences Circulating Tumor Cells Introduction
11.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2020-2025)
11.5.5 Epic Sciences Recent Development
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Details
11.6.2 Greiner Bio-one GmbH Business Overview
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction
11.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2020-2025)
11.6.5 Greiner Bio-one GmbH Recent Development
11.7 Cynvenio
11.7.1 Cynvenio Company Details
11.7.2 Cynvenio Business Overview
11.7.3 Cynvenio Circulating Tumor Cells Introduction
11.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2020-2025)
11.7.5 Cynvenio Recent Development
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Details
11.8.2 SurExamBio-Tech Business Overview
11.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction
11.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2020-2025)
11.8.5 SurExamBio-Tech Recent Development
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Details
11.9.2 Fluxion Biosciences Business Overview
11.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction
11.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2020-2025)
11.9.5 Fluxion Biosciences Recent Development
11.10 Ikonisys
11.10.1 Ikonisys Company Details
11.10.2 Ikonisys Business Overview
11.10.3 Ikonisys Circulating Tumor Cells Introduction
11.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2020-2025)
11.10.5 Ikonisys Recent Development
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Details
11.11.2 Hangzhou Watson Biotech Business Overview
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction
11.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2020-2025)
11.11.5 Hangzhou Watson Biotech Recent Development
11.12 Biocept
11.12.1 Biocept Company Details
11.12.2 Biocept Business Overview
11.12.3 Biocept Circulating Tumor Cells Introduction
11.12.4 Biocept Revenue in Circulating Tumor Cells Business (2020-2025)
11.12.5 Biocept Recent Development
11.13 CytoTrack
11.13.1 CytoTrack Company Details
11.13.2 CytoTrack Business Overview
11.13.3 CytoTrack Circulating Tumor Cells Introduction
11.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2020-2025)
11.13.5 CytoTrack Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2020-2025)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Celsee
11.15.1 Celsee Company Details
11.15.2 Celsee Business Overview
11.15.3 Celsee Circulating Tumor Cells Introduction
11.15.4 Celsee Revenue in Circulating Tumor Cells Business (2020-2025)
11.15.5 Celsee Recent Development
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Details
11.16.2 Clearbridge Biomedics Business Overview
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction
11.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2020-2025)
11.16.5 Clearbridge Biomedics Recent Development
11.17 ANGLE plc
11.17.1 ANGLE plc Company Details
11.17.2 ANGLE plc Business Overview
11.17.3 ANGLE plc Circulating Tumor Cells Introduction
11.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2020-2025)
11.17.5 ANGLE plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Circulating Tumor Cells Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Circulating Tumor Cells Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Circulating Tumor Cells Market Share by Region (2020-2025)
Table 9. Global Circulating Tumor Cells Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Circulating Tumor Cells Market Share by Region (2026-2031)
Table 11. Circulating Tumor Cells Market Trends
Table 12. Circulating Tumor Cells Market Drivers
Table 13. Circulating Tumor Cells Market Challenges
Table 14. Circulating Tumor Cells Market Restraints
Table 15. Global Circulating Tumor Cells Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Circulating Tumor Cells Market Share by Players (2020-2025)
Table 17. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2024)
Table 18. Ranking of Global Top Circulating Tumor Cells Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Circulating Tumor Cells, Headquarters and Area Served
Table 21. Global Key Players of Circulating Tumor Cells, Product and Application
Table 22. Global Key Players of Circulating Tumor Cells, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cells Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Circulating Tumor Cells Revenue Market Share by Type (2020-2025)
Table 26. Global Circulating Tumor Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Circulating Tumor Cells Revenue Market Share by Type (2026-2031)
Table 28. Global Circulating Tumor Cells Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Circulating Tumor Cells Revenue Market Share by Application (2020-2025)
Table 30. Global Circulating Tumor Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Circulating Tumor Cells Revenue Market Share by Application (2026-2031)
Table 32. North America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Circulating Tumor Cells Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Circulating Tumor Cells Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Circulating Tumor Cells Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Circulating Tumor Cells Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Circulating Tumor Cells Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Circulating Tumor Cells Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Circulating Tumor Cells Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Circulating Tumor Cells Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Circulating Tumor Cells Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Circulating Tumor Cells Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Circulating Tumor Cells Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Circulating Tumor Cells Market Size by Country (2026-2031) & (US$ Million)
Table 47. Menarini-Silicon Biosystems Company Details
Table 48. Menarini-Silicon Biosystems Business Overview
Table 49. Menarini-Silicon Biosystems Circulating Tumor Cells Product
Table 50. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 51. Menarini-Silicon Biosystems Recent Development
Table 52. Qiagen (Adnagen) Company Details
Table 53. Qiagen (Adnagen) Business Overview
Table 54. Qiagen (Adnagen) Circulating Tumor Cells Product
Table 55. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 56. Qiagen (Adnagen) Recent Development
Table 57. Advanced Cell Diagnostics Company Details
Table 58. Advanced Cell Diagnostics Business Overview
Table 59. Advanced Cell Diagnostics Circulating Tumor Cells Product
Table 60. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 61. Advanced Cell Diagnostics Recent Development
Table 62. ApoCell Company Details
Table 63. ApoCell Business Overview
Table 64. ApoCell Circulating Tumor Cells Product
Table 65. ApoCell Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 66. ApoCell Recent Development
Table 67. Epic Sciences Company Details
Table 68. Epic Sciences Business Overview
Table 69. Epic Sciences Circulating Tumor Cells Product
Table 70. Epic Sciences Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 71. Epic Sciences Recent Development
Table 72. Greiner Bio-one GmbH Company Details
Table 73. Greiner Bio-one GmbH Business Overview
Table 74. Greiner Bio-one GmbH Circulating Tumor Cells Product
Table 75. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 76. Greiner Bio-one GmbH Recent Development
Table 77. Cynvenio Company Details
Table 78. Cynvenio Business Overview
Table 79. Cynvenio Circulating Tumor Cells Product
Table 80. Cynvenio Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 81. Cynvenio Recent Development
Table 82. SurExamBio-Tech Company Details
Table 83. SurExamBio-Tech Business Overview
Table 84. SurExamBio-Tech Circulating Tumor Cells Product
Table 85. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 86. SurExamBio-Tech Recent Development
Table 87. Fluxion Biosciences Company Details
Table 88. Fluxion Biosciences Business Overview
Table 89. Fluxion Biosciences Circulating Tumor Cells Product
Table 90. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 91. Fluxion Biosciences Recent Development
Table 92. Ikonisys Company Details
Table 93. Ikonisys Business Overview
Table 94. Ikonisys Circulating Tumor Cells Product
Table 95. Ikonisys Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 96. Ikonisys Recent Development
Table 97. Hangzhou Watson Biotech Company Details
Table 98. Hangzhou Watson Biotech Business Overview
Table 99. Hangzhou Watson Biotech Circulating Tumor Cells Product
Table 100. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 101. Hangzhou Watson Biotech Recent Development
Table 102. Biocept Company Details
Table 103. Biocept Business Overview
Table 104. Biocept Circulating Tumor Cells Product
Table 105. Biocept Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 106. Biocept Recent Development
Table 107. CytoTrack Company Details
Table 108. CytoTrack Business Overview
Table 109. CytoTrack Circulating Tumor Cells Product
Table 110. CytoTrack Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 111. CytoTrack Recent Development
Table 112. Guangzhou Wondfo Biotech Company Details
Table 113. Guangzhou Wondfo Biotech Business Overview
Table 114. Guangzhou Wondfo Biotech Circulating Tumor Cells Product
Table 115. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 116. Guangzhou Wondfo Biotech Recent Development
Table 117. Celsee Company Details
Table 118. Celsee Business Overview
Table 119. Celsee Circulating Tumor Cells Product
Table 120. Celsee Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 121. Celsee Recent Development
Table 122. Clearbridge Biomedics Company Details
Table 123. Clearbridge Biomedics Business Overview
Table 124. Clearbridge Biomedics Circulating Tumor Cells Product
Table 125. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 126. Clearbridge Biomedics Recent Development
Table 127. ANGLE plc Company Details
Table 128. ANGLE plc Business Overview
Table 129. ANGLE plc Circulating Tumor Cells Product
Table 130. ANGLE plc Revenue in Circulating Tumor Cells Business (2020-2025) & (US$ Million)
Table 131. ANGLE plc Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells Picture
Figure 2. Global Circulating Tumor Cells Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells Market Share by Type: 2024 VS 2031
Figure 4. CTC Enrichment Features
Figure 5. CTC Detection Features
Figure 6. CTC Analysis Features
Figure 7. Global Circulating Tumor Cells Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Circulating Tumor Cells Market Share by Application: 2024 VS 2031
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Colorectal Cancer Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Circulating Tumor Cells Report Years Considered
Figure 15. Global Circulating Tumor Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Circulating Tumor Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Circulating Tumor Cells Market Share by Region: 2024 VS 2031
Figure 18. Global Circulating Tumor Cells Market Share by Players in 2024
Figure 19. Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2024
Figure 21. North America Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Circulating Tumor Cells Market Share by Country (2020-2031)
Figure 23. United States Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Circulating Tumor Cells Market Share by Country (2020-2031)
Figure 27. Germany Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Circulating Tumor Cells Market Share by Region (2020-2031)
Figure 35. China Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Circulating Tumor Cells Market Share by Country (2020-2031)
Figure 43. Mexico Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Circulating Tumor Cells Market Share by Country (2020-2031)
Figure 47. Israel Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Circulating Tumor Cells Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 51. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 52. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 53. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 54. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 55. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 56. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 57. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 58. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 59. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 60. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 61. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 62. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 63. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 64. Celsee Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 65. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 66. ANGLE plc Revenue Growth Rate in Circulating Tumor Cells Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Circulating Tumor Cells market?
The top companies in the global Circulating Tumor Cells market are Menarini-Silicon Biosystems、Qiagen (Adnagen)、Advanced Cell Diagnostics.
What is the annual compound growth rate of the global Circulating Tumor Cells market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Circulating Tumor Cells in 2031?
What was the global market size of Circulating Tumor Cells in 2025?
Related Reports
Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Circulating Tumor Cells market size was US$ 2711 million in 2025 and is forecast to reach a readjusted size of US$ 9775 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 110
USD 4250.00
(Single User License)
Global Circulating Tumor Cells Market Research Report 2026
The global Circulating Tumor Cells market was valued at US$ 2711 million in 2025 and is anticipated to reach US$ 9775 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 134
USD 2900.00
(Single User License)
Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Circulating Tumor Cells was estimated to be worth US$ 2711 million in 2025 and is projected to reach US$ 9775 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 122
USD 3950.00
(Single User License)
Global Circulating Tumor Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Circulating Tumor Cells market is projected to grow from US$ 2291 million in 2024 to US$ 8259 million by 2031, at a CAGR of 20.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 154
USD 4900.00
(Single User License)
Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-08-05
Pages: 127
USD 3950.00
(Single User License)
Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Circulating Tumor Cells market size was US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-08-05
Pages: 109
USD 4250.00
(Single User License)
Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Circulating Tumor Cells was estimated to be worth US$ 2291 million and is forecast to reach approximately US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 157
USD 5900.00
(Single User License)
Circulating Tumor Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 125
USD 3950.00
(Single User License)
Global Circulating Tumor Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Published Date: 2024-04-17
Pages: 176
USD 5600.00
(Single User License)
Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Published Date: 2024-04-16
Pages: 167
USD 5900.00
(Single User License)
Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Circulating Tumor Cells market size was US$ 2711 million in 2025 and is forecast to reach a readjusted size of US$ 9775 million by 2032 with a CAGR of 20.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 110
USD 4250.00 (Single User License)Global Circulating Tumor Cells Market Research Report 2026
The global Circulating Tumor Cells market was valued at US$ 2711 million in 2025 and is anticipated to reach US$ 9775 million by 2032, at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 134
USD 2900.00 (Single User License)Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Circulating Tumor Cells was estimated to be worth US$ 2711 million in 2025 and is projected to reach US$ 9775 million, growing at a CAGR of 20.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 122
USD 3950.00 (Single User License)Global Circulating Tumor Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Circulating Tumor Cells market is projected to grow from US$ 2291 million in 2024 to US$ 8259 million by 2031, at a CAGR of 20.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 154
USD 4900.00 (Single User License)Circulating Tumor Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-08-05
Pages: 127
USD 3950.00 (Single User License)Global Circulating Tumor Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Circulating Tumor Cells market size was US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-08-05
Pages: 109
USD 4250.00 (Single User License)Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Circulating Tumor Cells was estimated to be worth US$ 2291 million and is forecast to reach approximately US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 157
USD 5900.00 (Single User License)Circulating Tumor Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Circulating Tumor Cells was estimated to be worth US$ 2291 million in 2024 and is forecast to a readjusted size of US$ 8259 million by 2031 with a CAGR of 20.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 125
USD 3950.00 (Single User License)Global Circulating Tumor Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Published: 2024-04-17
Pages: 176
USD 5600.00 (Single User License)Global Circulating Tumor Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Published: 2024-04-16
Pages: 167
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now